Feb 27 – Mar 2, 2019 | Marco Island, FL

 

 

Call for Abstracts Now Open
Due October 1st

TUULI LAPPALAINEN

NEW YORK GENOME CENTER

ANDREW CLARK

CORNELL UNIVERSITY

KATHERINE S. POLLARD

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

AVIV REGEV

BROAD INSTITUTE OF MIT AND HARVARD

ANDREW CLARK

ANDREW CLARK

CORNELL UNIVERSITY
KATHERINE S. POLLARD

KATHERINE S. POLLARD

UNIVERSITY OF CALIFORNIA,
SAN FRANCISCO
AVIV REGEV

AVIV REGEV

BROAD INSTITUTE OF MIT AND HARVARD
TUULI LAPPALAINEN

TUULI LAPPALAINEN

NEW YORK GENOME CENTER
The cutting edge science, new applications, and access to true leaders always makes AGBT stand out.
— 2018 General Meeting Attendee

AGBT is a cornerstone in genomics and the most important meeting I attend all year.
— 2018 General Meeting Attendee

High level networking and discussion of hard core science and technology is why AGBT is exceptional.
— 2018 General Meeting Attendee

The 2019 Agenda is coming soon

AGBT 2019 Registration is open

See the

ATTEND IF YOU ARE

Scientists

Clinicians

Geneticists

Oncologists

Commercial scientists

Business sector leaders

Researchers

Bioinformaticians

ALL STAKEHOLDERS INTERESTED IN  ADVANCING THE INTERFACE OF GENOMICS, MEDICINE, AND HEALTH

ATTEND FOR

New discoveries in DNA and RNA sequencing technologies

Experimental and analytic approaches for genomic studies and applications

Clinical case studies Ground breaking research

The integration of genomics and pharmacogenomics to individualized patient care

Networking with top industry leaders

The Scientific
Organizing Committee

Penelope Bonnen, Baylor College of Medicine
Ken Dewar, McGill University and Genome Quebec Innovation Centre
Federica Di-Palma, Earlham Institute, University of East Anglia
Eric Green, National Human Genome Research Institute /National Institute of Health
Martin Hirst, University of British Columbia
Elaine Mardis, The Institute for Genomic Medicine at Nationwide Children’s Hospital
Christopher Mason, Weill Cornell Medicine
John McPherson, University of California Davis
Len Pennacchio, Lawrence Berkeley National Laboratory
Beth Shapiro, University of California Santa Cruz
Michael Zody, New York Genome Center